Related company info
Press release, January 20; Joseph Tsai, DIGITIMES
Tuesday 20 January 2009
  • Biostar Microtech International
  • Performance
    The company's stock price closed at NT$19.7 on the TSE on Tuesday, April 24, 2018.
    The company has reported consolidated revenues of NT$364 million for March 2018, representing a 37% increase on month and 14.3% increase on year.
    For the fourth quarter of 2017, the company totaled NT$814 million in consolidated revenues, down 2.2% sequentially and up 10.8% on year.
    Brief

    Full name: Biostar Microtech International

    Chinese name: 映泰股份有限公司

    Short name: Biostar

    Stock code: 2399

    Tax ID: 23826200

    Market: TSE

    Established: 29 Aug 1990

    Paid in capital: NT$1.78 billion

    Listed on TSE: 16 Dec 1999

    Website: www.biostar.com.tw

  • On display

    Biostar G41 chipset motherboard

    Biostar TA790GX A3+ motherboard

    Biostar TA760G M2+ motherboard

  • Latest stock
    Biostar [2399] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    25-Apr 7,495   19.35 20.45 19.05 20.25+0.55+2.79%  
    24-Apr 13,524 6,100 282,857,150 22.30 22.30 19.60 19.70-2.05-9.43% 19.65 19.70
    23-Apr 9,893 4,416 220,269,250 21.65 22.80 21.65 21.75-0.15-0.68% 21.75 21.80
    20-Apr 8,230 3,890 181,160,250 22.60 22.70 21.60 21.90-0.90-3.95% 21.90 21.95
    19-Apr 14,055 6,089 323,505,700 22.35 23.70 22.30 22.80+0.65+2.93% 22.80 22.85
    18-Apr 8,025 4,047 177,338,650 21.50 22.70 21.35 22.15+1.15+5.48% 22.15 22.20
    17-Apr 4,547 2,349 98,469,650 22.20 22.50 21.00 21.00-1.10-4.98% 21.00 21.10
    16-Apr 6,629 3,024 148,899,950 23.60 23.60 22.05 22.10-1.05-4.54% 22.10 22.20
    • Source: TSE, compiled by Digitimes
    Latest sales

    Biostar: Consolidated revenues, Mar 2017 - Mar 2018 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Mar-18

    364

    37%

    14.3%

    1,036

    33.1%

    Feb-18

    266

    (34.4%)

    5.4%

    671

    46.1%

    Jan-18

    405

    5.4%

    95.6%

    405

    95.6%

    Dec-17

    385

    64.3%

    72.1%

    3,443

    14.9%

    Nov-17

    234

    20%

    (12.2%)

    3,059

    10.3%

    Oct-17

    195

    (18.4%)

    (20%)

    2,824

    12.7%

    Sep-17

    239

    (1.9%)

    (14%)

    2,629

    16.2%

    Aug-17

    244

    (30.2%)

    (3.9%)

    2,390

    20.4%

    Jul-17

    349

    (22.9%)

    47.5%

    2,146

    24%

    Jun-17

    453

    32.7%

    75.6%

    1,797

    20.3%

    May-17

    341

    51.5%

    56.7%

    1,345

    8.7%

    Apr-17

    225

    (29.4%)

    (6.8%)

    1,004

    (1.5%)

    Mar-17

    319

    26.3%

    2.1%

    778

    0.1%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Biostar: Consolidated revenues, 4Q16 - 4Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    4Q-17

    814

    (2.2%)

    10.8%

    3,443

    14.9%

    3Q-17

    832

    (18.3%)

    8.3%

    2,629

    16.2%

    2Q-17

    1,019

    30.9%

    42.1%

    1,797

    20.3%

    1Q-17

    778

    6%

    0.1%

    778

    0.1%

    4Q-16

    735

    (4.4%)

    38.6%

    2,998

    5.9%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Latest balance sheet and income statement

    Biostar: Consolidated balance sheet, 4Q16 - 4Q17 (NT$k)

    Item

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    Current assets

    2,853,342

    2,740,256

    2,734,762

    2,539,657

    2,613,024

    Intangible assets

    171,024

    0

    Non-current assets

    851,730

    602,105

    555,881

    564,099

    560,044

    Assets

    3,705,072

    3,342,361

    3,290,643

    3,103,756

    3,173,068

    Current liabilities

    1,004,265

    887,094

    904,946

    790,561

    808,596

    Non-current liabilities

    69,436

    62,373

    56,774

    67,841

    74,112

    Liabilities

    1,073,701

    949,467

    961,720

    858,402

    882,708

    Stockholders' equity

    2,631,371

    2,392,894

    2,328,923

    2,245,354

    2,290,360

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

    Biostar: Consolidated income statement, 4Q16 - 4Q17 (NT$k)

    Item

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    814,150

     

    832,114

     

    1,018,721

     

    778,407

     

    734,589

     

    Gross profit (loss) from operations

    89,075

    10.9%

    133,723

    16.1%

    142,850

    14%

    89,536

    11.5%

    77,071

    10.5%

    Operating expenses

    94,861

    11.7%

    88,699

    10.7%

    79,736

    7.8%

    99,463

    12.8%

    119,404

    16.3%

    Operating income (loss)

    -5,786

    -0.7%

    45,024

    5.4%

    63,114

    6.2%

    -9,927

    -1.3%

    -42,333

    -5.8%

    Non-operating expenses and losses

    -7,328

    -0.9%

    15,581

    1.9%

    20,655

    2%

    -30,700

    -3.9%

    56,298

    7.7%

    Income from continuing operations before income tax

    -13,114

    -1.6%

    60,605

    7.3%

    83,769

    8.2%

    -40,627

    -5.2%

    13,965

    1.9%

    Net income (loss)

    -228

    0%

    58,635

    7%

    81,864

    8%

    -35,337

    -4.5%

    7,653

    1%

    Diluted earnings per share (NT$)

    -0

     

    0.3

     

    0.5

     

    -0.2

     

    0.1

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, April 2018

Realtime news

Global server market – 4Q 2017

Taiwan LCD monitors – 4Q 2017

Taiwan handsets – 4Q 2017

Global AP market, 2017-2021

Taiwan server shipment forecast and industry analysis, 2018

China AMOLED panel capacity expansion forecast, 2016-2020

© DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.